Przejdź do głównej treści

Widok zawartości stron Widok zawartości stron

Pomiń baner

Widok zawartości stron Widok zawartości stron

Molecular Mechanisms of Disease Research Group

Research topics at Molecular Mechanisms of Disease Group: 

iPSCs disease modeling in a dish headed by Dr. Neli Kachamakova-Trojanowska 
Pancreatic cancer researchrole of the microenvironment headed by Dr. Monika Jakubowska

Head of the group:

Dr. Neli Kachamakova-Trojanowska
phone: 12 664 6468, room 2/24





Team members:

Dr. Monika Jakubowska                                                         
Leader of the pancreatic cancer research                                                                 
phone: 12 664 6468; room 2/24 




Dr. Damian Klóska
topic: iPSCs disease modeling in a dish
phone: 12 664 6468; room 2/24



PhD student Kinga Stopa
(topic: pancreatic cancer) 




PhD student Daria Krzysztofik  
(topic: pancreatic cancer)




PhD student Dawid Skoczek
(topic: iPSCs disease modeling)





Dominika Drapała
Filip Łoziński
Aldona Szewczyk


2022-2024 Project PRELUDIUM 20, awarded to Daria Krzysztofik: "Long-term exposure to high copper: does it affect the production of pancreatic digestive enzymes?"
2021-2025 Project Sonata-Bis headed by Dr. Neli Kachamakova-Trojanowska: “Molecular background of microvascular complications in HNF1A-MODY patients: induced pluripotent stem cells as disease modeling tool
2021-2022 POB BIOS Minigrant awarded to Dr. Monika Jakubowska
Title: "Copper misbalance and impaired exocrine pancreatic functions - ex vivo analyses of the Atp7b toxic milk mouse model
2018-2021 Project OPUS headed by Dr. Neli Kachamakova-Trojanowska:“ Editing of HNF1A gene in human induced pluripotent stem cells with CRISPR/Cas9 for disease modeling of endothelial (dys)function in maturity onset diabetes of the young (MODY)” 
2018-2020 Project HOMING headed by Dr. Monika Jakubowska: “Targeting mechanisms of pancreatic cancer resistance against therapy: specific role of tumor microenvironment

Recent publications:
1. Skoczek et al., Maturity Onset Diabetes of the Young-New Approaches for Disease Modelling, Int J Mol Sci. 2021.
2. Kachamakova-Trojanowska et al., HIF-1 stabilization exerts anticancer effects in breast cancer cells in vitro and in vivo. Biochem Pharmacol. 2020 
3. Białopiotrowicz et al., Serine Biosynthesis Pathway Supports MYC-miR-494-EZH2 Feed-Forward Circuit Necessary to Maintain Metabolic and Epigenetic Reprogramming of Burkitt Lymphoma Cells. Cancers (Basel). 2020
4. Szade et al., Heme oxygenase-1 deficiency triggers exhaustion of hematopoietic stem cells. EMBO Rep. 2020
5. Rozga et al., Novel engineered TRAIL-based chimeric protein strongly inhibits tumor growth and bypasses TRAIL resistance. Int J Cancer. 2019
6. Kachamakova-Trojanowska et al., Human iPSCs-Derived Endothelial Cells with Mutation in HNF1A as a Model of Maturity-Onset Diabetes of the Young, Cells. 2019
7. Szade et al., Cobalt protoporphyrin IX increases endogenous G-CSF and mobilizes HSC and granulocytes to the blood. EMBO Mol Med. 2019
8. Nowak et al., Atorvastatin and Conditioned Media from Atorvastatin-Treated Human Hematopoietic Stem/Progenitor-Derived Cells Show Proangiogenic Activity In Vitro but Not In Vivo. Mediators Inflamm. 2019
9. Mucha et al., Development and characterization of a new inhibitor of heme oxygenase activity for cancer treatment. Arch Biochem Biophys. 2019
10. Šmíd et al., Heme Oxygenase-1 May Affect Cell Signalling via Modulation of Ganglioside Composition. Oxid Med Cell Longev. 2018.
11. Kachamakova-Trojanowska et al., Molecular profiling of regulatory T cells in pulmonary sarcoidosis. J Autoimmun. 2018
12. Mucha et al., Pharmacological versus genetic inhibition of heme oxygenase-1 - the comparison of metalloporphyrins, shRNA and CRISPR/Cas9 system. Acta Biochim Pol. 2018
13. Stepniewski et al., Heme oxygenase-1 affects generation and spontaneous cardiac differentiation of induced pluripotent stem cells. IUBMB Life. 2018